Weibin Hou

Chinese Academy of Medical Sciences & Peking Union Medical College, Central South University

Papers

Total Citations

H-Index

About

Dr. Weibin Hou is a pioneering urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for urologic cancers, with a particular focus on reducing patient morbidity. His most impactful contribution, a 2015 systematic review on achieving zero ischemia in minimally invasive partial nephrectomy (MIPN), has garnered 22 citations and helped shift the paradigm in kidney-sparing surgery. By systematically evaluating techniques to eliminate warm ischemia time—a major barrier to the widespread adoption of laparoscopic and robotic partial nephrectomy—Dr. Hou provided a critical roadmap for safer, more effective procedures. He has also innovated in the management of penile cancer, introducing a novel technique for Indocyanine Green fluorescence imaging-guided robotic bilateral inguinal lymphadenectomy via a hypogastric subcutaneous approach (2022). This work aims to improve the efficiency of lymph node dissection while reducing surgical complications. Further demonstrating his technical expertise, Dr. Hou has compared single-site multiport versus conventional multiport robot-assisted radical prostatectomy (RARP), using propensity score matching to evaluate outcomes. His research consistently pushes the boundaries of robotic surgery, striving for greater precision, less invasiveness, and better patient recovery.